Cell Culture Process Development focuses on optimizing the cultivation conditions of recombinant cell lines to establish robust and scalable upstream manufacturing processes for biologics production. Protheragen provides comprehensive cell culture process development services, including clone evaluation, media optimization, shake flask and bioreactor process development, scale-up support, and process characterization for antibody and AOC programs.
Overview of Antibody & AOC Cell Culture Process Development
Cell culture process development is a critical component of biologics manufacturing that focuses on optimizing the growth conditions and production performance of recombinant cell lines. Following cell line development, selected production clones undergo systematic evaluation and optimization to improve cell growth, productivity, product quality, and process robustness.
Key activities typically include cell culture parameter optimization, media and feed strategy development, shake flask and bioreactor studies, scale-up assessment, and process characterization. For mammalian expression systems such as CHO cells, optimized upstream processes help ensure consistent production performance while maintaining critical quality attributes of therapeutic proteins throughout clinical development and commercial manufacturing.
Our Services
Our cell culture process development services cover the full upstream development workflow, from clone evaluation and media optimization to bioreactor process development, scale-up, and process characterization. By integrating systematic process optimization with scalable development strategies, we help establish robust, reproducible, and manufacturing-ready cell culture processes.
Protein Sample Preparation & Clone Evaluation
Following cell line development, selected clones undergo initial expression evaluation to identify candidates with optimal growth characteristics, productivity, and product quality profiles.
Activities include:
Cell growth and viability assessment
Expression level evaluation
Clone productivity comparison
Product quality attribute assessment
Media Screening & Optimization
Customized media development strategies are applied to improve cell growth, productivity, and product quality consistency.
Services include:
Basal media screening
Feed strategy optimization
Nutrient supplementation evaluation
Metabolic profile analysis
Shake Flask & Bioreactor Process Optimization
Process parameters are systematically optimized from laboratory scale to bioreactor systems to establish robust upstream production processes.
Optimization parameters include:
Temperature shift strategies
pH and dissolved oxygen control
Feeding strategies
Cell density management
Culture duration optimization
Bioreactor Process Development
Our platform supports scalable upstream process development using advanced single-use bioreactor systems.
Capabilities include:
Fed-batch process development
Intensified N-1 perfusion strategies
Process parameter optimization
Scale-up strategy development
Clarification Process Development
Optimization of harvest processing enables efficient removal of cells and impurities while maintaining product recovery.
Services include:
Cell removal optimization
Centrifugation condition evaluation
Depth filtration studies
Harvest process robustness assessment
Process Lock, Technology Transfer & Scale-Up
Following process optimization, we support process definition and transfer activities to ensure manufacturing readiness.
Support includes:
Process parameter definition
Scale-up strategy development
Technology transfer support
Manufacturing process preparation
Technology Platform
Our upstream process development laboratories are equipped with laboratory-scale bioreactor systems and advanced process analytical technologies to support rapid process optimization and scale-up evaluation.
Capabilities include:
Multiple laboratory bioreactor systems for parallel process development
Automated cell analysis platforms
Blood gas and metabolite monitoring systems
High-throughput analytical instruments for culture performance evaluation
Applications
Protheragen applies integrated cell culture process development expertise to address diverse upstream development needs across the product lifecycle. From early-stage process establishment and productivity enhancement to process robustness, scale-up, and manufacturing readiness, our team supports the development of scalable and reproducible cell culture processes tailored to each program.
Application Area
Development Focus
Early-Stage Process Development
Establishing initial cell culture conditions and upstream processes for early development programs.
Productivity Enhancement
Optimizing media, feeding strategies, cell density, and culture parameters to improve process productivity.
Process Robustness & Quality Consistency
Characterizing key process parameters and operating ranges to enhance process robustness and maintain consistent product quality.
Scale-Up & Manufacturing Readiness
Translating optimized processes to larger bioreactor systems and preparing robust processes for clinical and commercial manufacturing.
Why Choose Protheragen
Extensive Biologics Development Experience
Supporting cell culture process development for monoclonal antibodies, bispecific antibodies, fusion proteins, and other complex biologics.
End-to-End Upstream Development Support
Providing integrated solutions from clone evaluation and media optimization to bioreactor development, scale-up, and process characterization.
Advanced Process Optimization Capabilities
Leveraging bioreactor systems and analytical platforms to identify optimal culture conditions and improve process performance.
Scalable Manufacturing-Oriented Solutions
Developing robust and transferable upstream processes suitable for clinical development and commercial manufacturing.
Featured Case Studies
Protheragen applies integrated upstream process development strategies to address challenges in complex antibody manufacturing, including accelerated timelines, clone selection uncertainty, process optimization, and scale-up consistency. The following cases demonstrate our capabilities in establishing robust cell culture processes from early development through clinical-stage manufacturing.
Accelerated Cell Culture Process Development for a Bispecific Antibody Program
A rapid upstream process development strategy was implemented for a time-sensitive bispecific antibody program, enabling successful scale-up to 200 L toxicology batch production with consistent performance and high productivity.
Late-Stage Cell Culture Process Optimization for Improved Antibody Productivity
An optimized upstream process was developed for a Phase II antibody program, increasing productivity by approximately 80% while maintaining consistent product quality attributes.
Protheragen leverages advanced upstream process development capabilities to help clients establish robust and scalable cell culture processes for antibody and AOC programs. From early-stage clone evaluation and process optimization to scale-up support and process characterization, we provide integrated solutions designed to improve productivity, ensure process consistency, and accelerate biologics development toward clinical and commercial manufacturing. Contact us to explore customized cell culture process development solutions for your next-generation antibody therapeutics.
